Mark J. Vignola - 31 May 2024 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Financial Officer
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Mark J. Vignola
Issuer symbol
TERN
Transactions as of
31 May 2024
Net transactions value
+$21,272
Form type
4
Filing time
04 Jun 2024, 18:05:58 UTC
Previous filing
25 Jan 2024
Next filing
12 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $21,272 +4,791 +5.5% $4.44 91,940 31 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes the purchase of 4,791 shares under the Terns Employee Stock Purchase Plan on May 31, 2024.

Remarks:

Voluntary reporting of ESPP purchase